Search News

Corporate Industry Technology Medical Updates

Ventricular Assist Device

Corporate
National Recognition: magAssist Certified as a High-Tech Enterprise, Strengthening the Foundation of Domestic Multi-Organ Life Support Innovation 2025-12-02
Medical Updates
Ventricular Assist Device Support for High-Risk PCI in a Patient with Acute Myocardial Infarction and Cardiogenic Shock 2025-09-26
Medical Updates
A Case Report: Use of Ventricular Assist Device to Enable High-Risk PCI in a Patient with Severe Left Ventricular Dysfunction 2025-09-07
Industry
Academic Symposium at Zhujiang Hospital Highlights Advances in Heart Failure Treatment with Extracorporeal VAD 2025-08-15
Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12
Medical Updates
High-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation 2025-04-02
Industry
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Industry
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26

Tabs： medical device, percutaneous intervention, Mechatronics, How to Choose Extra-VAD or ECMO, high-end medical devices, Chinese heart failure patients, cardiovascular disease patients, the extracorporeal maglev artificial heart, extracorporeal blood pumps, high-end innovative medical device,